iBio, Inc. (IBIO)
NYSEAMERICAN: IBIO · IEX Real-Time Price · USD
4.060
+0.700 (20.83%)
Mar 28, 2024, 4:00 PM EDT - Market closed

iBio, Inc. Income Statement

Millions USD. Fiscal year is Jul - Jun.
Year 2023202220212020201920182017201620152014 2013 - 2009
Revenue
01.882.371.642.020.440.390.951.850.21
Upgrade
Revenue Growth (YoY)
--20.54%44.75%-18.83%354.50%12.69%-58.44%-48.78%802.93%-79.64%
Upgrade
Cost of Revenue
001.460.7000000
Upgrade
Gross Profit
01.880.910.942.020.440.390.951.850.21
Upgrade
Selling, General & Admin
19.0221.7522.0311.3712.3310.6910.557.695.024.2
Upgrade
Research & Development
10.339.839.993.575.473.994.123.163.5-0.15
Upgrade
Operating Expenses
29.3431.5832.0214.9417.8114.6714.6710.848.524.05
Upgrade
Operating Income
-29.34-29.7-31.11-14-15.79-14.23-14.27-9.89-6.67-3.84
Upgrade
Interest Expense / Income
0.0802.452.471.91.921.930.8100.12
Upgrade
Other Expense / Income
35.5820.69-10.36-0.03-0.1-0.04-1.67-0.94-0.04-0.3
Upgrade
Pretax Income
-65.01-50.39-23.21-16.44-17.59-16.11-14.53-9.76-6.63-3.67
Upgrade
Net Income
-65.01-50.39-23.21-16.44-17.59-16.11-14.53-9.76-6.63-3.67
Upgrade
Preferred Dividends
000.2621.820.260.260.09000
Upgrade
Net Income Common
-65.01-50.39-23.47-38.26-17.85-16.37-14.62-9.76-6.63-3.67
Upgrade
Shares Outstanding (Basic)
1000000000
Upgrade
Shares Outstanding (Diluted)
1000000000
Upgrade
Shares Change
40.41%11.45%211.53%231.79%78.03%19.30%10.05%13.26%13.54%27.52%
Upgrade
EPS (Basic)
-106.20-115.60-60.00-305.00-470.00-770.00-820.00-600.00-450.00-300.00
Upgrade
EPS (Diluted)
-106.20-115.60-60.00-305.00-470.00-770.00-820.00-600.00-450.00-300.00
Upgrade
Free Cash Flow
-33.57-49.11-35.23-14.5-14.97-14.56-14.76-8.14-4.94-4.38
Upgrade
Free Cash Flow Per Share
-54.84-112.63-90.03-115.45-395.36-684.74-827.97-502.62-345.48-347.39
Upgrade
Gross Margin
-100.00%38.34%57.08%100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
--1576.27%-1312.15%-854.88%-782.36%-3204.28%-3622.84%-1043.57%-360.13%-1873.17%
Upgrade
Profit Margin
--2674.68%-989.75%-2335.78%-884.69%-3685.81%-3711.17%-1029.96%-357.91%-1788.29%
Upgrade
Free Cash Flow Margin
--2606.69%-1485.70%-885.16%-741.58%-3279.05%-3745.18%-858.65%-266.88%-2134.15%
Upgrade
EBITDA
-63.55-46.6-18.34-11.73-13.94-12.48-10.93-8.02-6.26-3.18
Upgrade
EBITDA Margin
--2473.46%-773.47%-716.24%-690.98%-2811.04%-2773.35%-845.68%-338.30%-1552.68%
Upgrade
Depreciation & Amortization
1.383.792.412.241.751.711.680.940.360.36
Upgrade
EBIT
-64.93-50.39-20.75-13.97-15.69-14.19-12.6-8.96-6.63-3.54
Upgrade
EBIT Margin
--2674.68%-875.28%-853.05%-777.65%-3195.95%-3198.73%-944.83%-357.91%-1728.78%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).